Labiotech.eu

News and Trends 2 Oct 2017

Meet the Young CEO of a PCR Workflow Automation Company

He is a young entrepreneur with a fast growing company. His software for the automation of PCR results interpretation in research laboratories has had a rocket start. Here’s his story! “I was looking for an internship for my bachelor’s degree in computer science…” His story starts like so many others, but unlike most it took […]

October 2, 2017 - 7 minutesmins - By External Contributor

News and Trends 2 Oct 2017

Update: The EU Approval of Dupixent Might Bring its Pricing Polemic to Europe

Update (01/10/2017): The European Commission has tighter control over pricing that governments have over here Images via Tero Vesalainen, Roman Stetsyk /Shutterstock

October 2, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 30 Sep 2017

The Art of Darya Warner: Bacterial Portraits, Meaty Tomatoes and Bioluminescence

From beautiful microscopic stills to designing the technology of the future, artist Darya Warner captures the beauty of life in her work. Darya Warner is an artist originally from Belarus, now based in the US, with an eye to spot beauty under the light of the microscope. From genetically engineered fluorescent E. coli to cauliflower, […]

September 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Sep 2017

Austrian Scientists Turn Human Bone into Surgical Screws

An alternative approach for the repair of broken bones is being developed in Austria, which would overcome major limitations of metal surgical screws. Researchers from TU Graz, Austria, are working with the start-up surgebright to develop surgical screws from donated human bone for foot and jaw surgery. Metal screws are the current standard but these have major limitations […]

September 29, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Sep 2017

French Microbiome Biotech Gets a €6.5M Leg Up to Market Launch

LNC Therapeutics is ready to take its oral microbiome-based therapeutic to market for obesity. Investors have contributed a bit of cash to get it there. Bordeaux-based LNC Therapeutics has raked in €6.5M in a Series C. It has raised a total of €16.5M since it was founded in 2010. Seventure Partners, a leading VC focused […]

September 28, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 28 Sep 2017

German Pharma Enters the Clinic with Solid Tumor Treatment

A Phase I study will investigate the safety and tolerability of Immatics approach to treating solid tumors. Immatics is a German biopharma based in Tuebingen, which is a leader in the field of cancer immunotherapy. It has announced today the initiation of a Phase I trial that will test the safety and tolerability of its […]

September 28, 2017 - 2 minutesmins - By Alex Dale

Interview 28 Sep 2017

What are Alphabodies and How Do They Drug the Undruggable?

Philip found out more about a new form of protein therapeutics being developed by Complix, which aims to drug the undruggable. Mark Vaeck, Co-Founder and CEO of Complix, has over 25 years experience in the biotech and pharma industries. His latest company Complix, a Belgian immuno-oncology biotech, is developing Alphabodies, tiny therapeutic proteins that can […]

September 28, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Sep 2017

Everyone Wants a Piece of this Scottish Biotech’s AI

Evotec has doubled down on its investment in Exscientia: the German outfit just announced it has invested €15M to take a minority stake. Sanofi, GSK and Evotec have all jumped at the opportunity to work with Exscientia, a Scottish startup founded in 2012 and incubating in Dundee. Now, Evotec has gone beyond the initial immuno-oncology deal […]

September 28, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 28 Sep 2017

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs

Nightstar has gone public on the American market with the aim of raising $75M for its gene-based retinal disease cures. Spun out from Oxford in 2013, Nightstar is developing and commercializing one-shot gene therapies for various eye diseases that could lead to blindness. This morning, it debuted on the Nasdaq with a projected $75M (£56M / €64M) […]

September 28, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 28 Sep 2017

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Abivax’s HIV cure candidate, ABX464, caused a significant drop in the viral reservoir over an extended period during a Phase IIa study. Abivax targets the immune system to cure viral diseases. The company has announced initial results from the first cohort of patients in its most recent Phase IIa trial testing its potential HIV cure, ABX464. Initial […]

September 28, 2017 - 2 minutesmins - By Alex Dale

Inside Labiotech 28 Sep 2017

Why does Labiotech.eu exist? (Not only to play table football together)

Our mission, since we started Labiotech.eu, has been to empower biotech ecosystems to better cure, feed and fuel the world. In our team, we all believe biotech is an industry that has an enormous impact on making the world a better place (I can’t actually think of any more impactful industry). Bill Gates recently told […]

September 28, 2017 - 3 minutesmins - By Philip Hemme

Interview 28 Sep 2017

Ethical Drug Development can Start with Charity Investors: A Conversation

As the furor over drug pricing has driven the biopharma industry to reflect on its ethics, I sat down with David Pardoe of LifeArc to discuss the involvement of charity investors. In August, a story emerged that Novartis CEO Joe Jimenez not only responded to a patient’s letter but met with him soon thereafter to […]

September 28, 2017 - 6 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the Young CEO of a PCR Workflow Automation Company

Update: The EU Approval of Dupixent Might Bring its Pricing Polemic to Europe

The Art of Darya Warner: Bacterial Portraits, Meaty Tomatoes and Bioluminescence

Austrian Scientists Turn Human Bone into Surgical Screws

French Microbiome Biotech Gets a €6.5M Leg Up to Market Launch

German Pharma Enters the Clinic with Solid Tumor Treatment

What are Alphabodies and How Do They Drug the Undruggable?

Everyone Wants a Piece of this Scottish Biotech’s AI

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Why does Labiotech.eu exist? (Not only to play table football together)

Ethical Drug Development can Start with Charity Investors: A Conversation

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!